We are live on ! Find out more
VCYT icon

Veracyte

50 hedge funds and large institutions have $150M invested in Veracyte in 2014 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 3

178% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 9

19% more funds holding

Funds holding: 4250 (+8)

8% more capital invested

Capital invested by funds: $140M → $150M (+$10.6M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
50
Holders Change
+8
Holders Change %
+19.05%
% of All Funds
1.44%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
11
Increased
25
Reduced
9
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
51
Deutsche Bank
Germany
-$739K -51,340 -100%
HCMT
52
Highland Capital Management (Texas)
Texas
-$461K -26,920 Closed

VCYT Hedge Fund Activity: Q2 2014 in Review

50 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2014, worth a combined $150M — up 7.6% from $140M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new VCYT positions and 3 closed out — a net gain of 8 holders — while 25 added to existing stakes and 9 trimmed.

The largest buyer was Pier Capital, opening a new position worth an estimated $2.86M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $3.19M sold.

  • 50 institutional investors held Veracyte (VCYT) as of Q2 2014, up from 42 in Q1 2014.
  • Funds reported $150M of Veracyte stock for Q2 2014, up 7.6% quarter-over-quarter.
  • 11 funds opened new Veracyte positions in Q2 2014 and 3 closed out, a net change of +8 holders.
  • The largest Veracyte buyer in Q2 2014 was Pier Capital, an estimated $2.86M added.
  • The largest Veracyte seller in Q2 2014 was Alyeska Investment Group, an estimated $3.19M sold.

Based on aggregated 13F filings for Q2 2014.